The thromboplastic activity of Russell's viper venom and its relationship to factor VII.
作者信息
JENKINS J S
出版信息
J Clin Pathol. 1954 Nov;7(4):287-9. doi: 10.1136/jcp.7.4.287.
Abstract
摘要
相似文献
1
The thromboplastic activity of Russell's viper venom and its relationship to factor VII.罗素蝰蛇毒的促凝血活性及其与凝血因子VII的关系。
J Clin Pathol. 1954 Nov;7(4):287-9. doi: 10.1136/jcp.7.4.287.
2
The coagulant action of Russell viper venom investigated by the thromboplastin generation test.通过凝血活酶生成试验研究罗素蝰蛇毒的凝血作用。
J Clin Pathol. 1956 Aug;9(3):237-41. doi: 10.1136/jcp.9.3.237.
3
Determining prothrombin clotting time using Russell's viper venom as thromboplastic substance.使用罗素蝰蛇毒作为凝血活酶物质测定凝血酶原凝血时间。
Bull U S Army Med Dep. 1946 Feb;5:242-4.
4
The coagulation of blood by Russell's viper venom; a reaction between Russell's viper venom and beef serum factors.罗素蝰蛇毒致血液凝固；罗素蝰蛇毒与牛血清因子之间的反应。
J Lab Clin Med. 1958 Jul;52(1):101-8.
5
The effect of incubation of plasma with Russell's viper venom on the recalcification clotting time.用罗素蝰蛇毒孵育血浆对复钙凝血时间的影响。
Scand J Clin Lab Invest. 1959;11:348-50. doi: 10.3109/00365515909060463.
6
The role of calcium and divalent metals in the coagulation of blood as induced by Russell's viper venom.钙和二价金属在罗素蝰蛇毒诱导的血液凝固中的作用。
Thromb Diath Haemorrh. 1961 Jul 15;6:118-24.
7
Formation of thromboplastic activity with Russell's viper venom.罗素蝰蛇毒诱导血栓形成活性的产生。
J Lab Clin Med. 1961 May;57:703-10.
8
A comparison of the effects of certain phosphatides and of chylomicra on plasma coagulation in the presence of Russell's viper venom.在存在罗素蝰蛇毒的情况下，某些磷脂和乳糜微粒对血浆凝血作用的比较。
Q J Exp Physiol Cogn Med Sci. 1956 Jan;41(1):31-5. doi: 10.1113/expphysiol.1956.sp001160.
9
The inhibition of Russell's viper venom by the water-soluble derivatives of sodium-copper chlorophyllin.叶绿素铜钠的水溶性衍生物对罗素蝰蛇毒的抑制作用。
Am J Surg. 1960 Jan;99:48-9. doi: 10.1016/0002-9610(60)90248-8.
10
Clotting of blood with Russell's viper venom.用罗素蝰蛇毒使血液凝固。
J Mich State Med Soc. 1955 Jul;54(7):801-4; passim.
引用本文的文献
1
Studies on the differences in activity of lung and brain thromboplastin.肺和脑凝血活酶活性差异的研究。
J Clin Invest. 1961 Feb;40(2):205-14. doi: 10.1172/JCI104246.
2
Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.斯图尔特凝血缺陷。I. 从迄今为止称为稳定因子（血清凝血酶原转变加速素、前转变素、因子VII）缺乏的异质性组中分离出一种遗传性出血状态。
J Clin Invest. 1957 Mar;36(3):485-96. doi: 10.1172/JCI103446.
3
The coagulant action of Russell viper venom investigated by the thromboplastin generation test.通过凝血活酶生成试验研究罗素蝰蛇毒的凝血作用。
J Clin Pathol. 1956 Aug;9(3):237-41. doi: 10.1136/jcp.9.3.237.
本文引用的文献
1
Co-thromboplastin, a probable factor in coagulation of blood.凝血活酶原，血液凝固中的一个可能因素。
Am J Physiol. 1951 Jan;164(1):105-10. doi: 10.1152/ajplegacy.1950.164.1.105.
2
Haemorrhagic diathesis due to deficiency of factor VII.因凝血因子 VII 缺乏所致的出血素质
J Clin Pathol. 1954 Feb;7(1):29-31. doi: 10.1136/jcp.7.1.29.
3
Mode of action of tromexan.氨甲环酸的作用机制。
Lancet. 1953 Apr 25;1(6765):821-3. doi: 10.1016/s0140-6736(53)91951-5.
Zotero 插件